Screening for coronary artery disease in asymptomatic individuals: Why and how?
Identifieur interne : 000745 ( Main/Exploration ); précédent : 000744; suivant : 000746Screening for coronary artery disease in asymptomatic individuals: Why and how?
Auteurs : Philippe Degrell [France] ; Emmanuel Sorbets [France] ; Laurent J. Feldman [France] ; Philippe Gabriel Steg [Royaume-Uni] ; Gregory Ducrocq [France]Source :
- Archives of cardiovascular diseases [ 1875-2128 ] ; 2015.
Abstract
Cardiovascular disease is still the main cause of death in the world, and coronary artery disease is the largest contributor. Screening asymptomatic individuals for coronary artery disease in view of preventive treatment is therefore of crucial interest. Apart from established risk scores based on traditional risk factors such as the Framingham or SCORE risk scores, new biomarkers and imaging methods have emerged (high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and secretory phospholipase A2, coronary artery calcium score, carotid intima-media thickness and ankle-brachial index). Their added value on top of the classic risk scores varies considerably and the most convincing evidence exists for coronary artery calcium score in intermediate-risk asymptomatic individuals.
DOI: 10.1016/j.acvd.2015.10.001
PubMed: 26596251
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000029
- to stream PubMed, to step Curation: 000029
- to stream PubMed, to step Checkpoint: 000036
- to stream Ncbi, to step Merge: 000215
- to stream Ncbi, to step Curation: 000208
- to stream Ncbi, to step Checkpoint: 000208
- to stream Main, to step Merge: 000734
- to stream Main, to step Curation: 000745
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Screening for coronary artery disease in asymptomatic individuals: Why and how?</title><author><name sortKey="Degrell, Philippe" sort="Degrell, Philippe" uniqKey="Degrell P" first="Philippe" last="Degrell">Philippe Degrell</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Sorbets, Emmanuel" sort="Sorbets, Emmanuel" uniqKey="Sorbets E" first="Emmanuel" last="Sorbets">Emmanuel Sorbets</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Feldman, Laurent J" sort="Feldman, Laurent J" uniqKey="Feldman L" first="Laurent J" last="Feldman">Laurent J. Feldman</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Steg, Philippe Gabriel" sort="Steg, Philippe Gabriel" uniqKey="Steg P" first="Philippe Gabriel" last="Steg">Philippe Gabriel Steg</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France; National Heart and Lung Institute, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France; National Heart and Lung Institute, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Ducrocq, Gregory" sort="Ducrocq, Gregory" uniqKey="Ducrocq G" first="Gregory" last="Ducrocq">Gregory Ducrocq</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France. Electronic address: gregory.ducrocq@bch.aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26596251</idno><idno type="pmid">26596251</idno><idno type="doi">10.1016/j.acvd.2015.10.001</idno><idno type="wicri:Area/PubMed/Corpus">000029</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000029</idno><idno type="wicri:Area/PubMed/Curation">000029</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000029</idno><idno type="wicri:Area/PubMed/Checkpoint">000036</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000036</idno><idno type="wicri:Area/Ncbi/Merge">000215</idno><idno type="wicri:Area/Ncbi/Curation">000208</idno><idno type="wicri:Area/Ncbi/Checkpoint">000208</idno><idno type="wicri:Area/Main/Merge">000734</idno><idno type="wicri:Area/Main/Curation">000745</idno><idno type="wicri:Area/Main/Exploration">000745</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Screening for coronary artery disease in asymptomatic individuals: Why and how?</title><author><name sortKey="Degrell, Philippe" sort="Degrell, Philippe" uniqKey="Degrell P" first="Philippe" last="Degrell">Philippe Degrell</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Sorbets, Emmanuel" sort="Sorbets, Emmanuel" uniqKey="Sorbets E" first="Emmanuel" last="Sorbets">Emmanuel Sorbets</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Feldman, Laurent J" sort="Feldman, Laurent J" uniqKey="Feldman L" first="Laurent J" last="Feldman">Laurent J. Feldman</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Steg, Philippe Gabriel" sort="Steg, Philippe Gabriel" uniqKey="Steg P" first="Philippe Gabriel" last="Steg">Philippe Gabriel Steg</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France; National Heart and Lung Institute, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France; National Heart and Lung Institute, Royal Brompton Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Ducrocq, Gregory" sort="Ducrocq, Gregory" uniqKey="Ducrocq G" first="Gregory" last="Ducrocq">Gregory Ducrocq</name><affiliation wicri:level="3"><nlm:affiliation>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris, France. Electronic address: gregory.ducrocq@bch.aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département hospitalo-universitaire fibrose, inflammation, remodelage (FIRE), French Alliance for Cardiovascular clinical Trials (FACT) and F-CRIN network, université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Hôpital Bichat and hôpital Avicenne, Assistance publique-Hôpitaux de Paris, hôpitaux universitaires Paris Nord Val-de-Seine, Paris, France; Inserm U-1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">Archives of cardiovascular diseases</title><idno type="eISSN">1875-2128</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cardiovascular disease is still the main cause of death in the world, and coronary artery disease is the largest contributor. Screening asymptomatic individuals for coronary artery disease in view of preventive treatment is therefore of crucial interest. Apart from established risk scores based on traditional risk factors such as the Framingham or SCORE risk scores, new biomarkers and imaging methods have emerged (high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and secretory phospholipase A2, coronary artery calcium score, carotid intima-media thickness and ankle-brachial index). Their added value on top of the classic risk scores varies considerably and the most convincing evidence exists for coronary artery calcium score in intermediate-risk asymptomatic individuals.</div></front></TEI><affiliations><list><country><li>France</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Île-de-France</li></region><settlement><li>Londres</li><li>Paris</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Degrell, Philippe" sort="Degrell, Philippe" uniqKey="Degrell P" first="Philippe" last="Degrell">Philippe Degrell</name></region><name sortKey="Ducrocq, Gregory" sort="Ducrocq, Gregory" uniqKey="Ducrocq G" first="Gregory" last="Ducrocq">Gregory Ducrocq</name><name sortKey="Feldman, Laurent J" sort="Feldman, Laurent J" uniqKey="Feldman L" first="Laurent J" last="Feldman">Laurent J. Feldman</name><name sortKey="Sorbets, Emmanuel" sort="Sorbets, Emmanuel" uniqKey="Sorbets E" first="Emmanuel" last="Sorbets">Emmanuel Sorbets</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Steg, Philippe Gabriel" sort="Steg, Philippe Gabriel" uniqKey="Steg P" first="Philippe Gabriel" last="Steg">Philippe Gabriel Steg</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000745 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000745 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Lorraine
|area= InforLorV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26596251
|texte= Screening for coronary artery disease in asymptomatic individuals: Why and how?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26596251" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a InforLorV4
| This area was generated with Dilib version V0.6.33. |  |